Aripiprazole tablets have the effect of blocking 5-hydroxytryptamine receptors and adrenergic receptors and work to treat schizophrenia.
Aripiprazole tablets are an atypical antipsychotic drug, and the efficacy of aripiprazole for the treatment of schizophrenia was established in short-term (4- and 6-week) controlled trials in patients with schizophrenia. However, it is important to note before use that aripiprazole tablets for dementia-related psychosis can increase the risk of death in patients.
Use of the drug may also cause adverse reactions such as weight gain and abnormal laboratory tests, and it is contraindicated in patients with known hypersensitivity to the product. Pregnant women should only use it if the potential benefit to the fetus outweighs the potential risk. Nursing women taking Aripiprazole should discontinue breastfeeding.
The use of Aripiprazole tablets should be standardized under the guidance of a doctor, do not use the drug privately to cause dizziness, hypotension and other symptoms, the emergence of psychiatric disorders is recommended to go to the hospital to receive treatment.